Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,158 | 1,142 | 99.8% |
| Education | $31.57 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,491 | 168 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,299 | 89 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $1,425 | 110 | $0 (2022) |
| Amgen Inc. | $1,235 | 83 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,019 | 94 | $0 (2020) |
| GlaxoSmithKline, LLC. | $935.25 | 96 | $0 (2022) |
| Merck Sharp & Dohme LLC | $880.34 | 85 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $834.13 | 78 | $0 (2022) |
| ABBVIE INC. | $626.24 | 41 | $0 (2022) |
| Lilly USA, LLC | $547.96 | 116 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,625 | 100 | Novo Nordisk Inc ($334.14) |
| 2021 | $2,443 | 152 | Novo Nordisk Inc ($383.20) |
| 2020 | $1,910 | 124 | AstraZeneca Pharmaceuticals LP ($407.23) |
| 2019 | $2,809 | 261 | Novo Nordisk Inc ($406.12) |
| 2018 | $3,022 | 230 | Novo Nordisk Inc ($552.96) |
| 2017 | $3,381 | 281 | AstraZeneca Pharmaceuticals LP ($613.02) |
All Payment Transactions
1,148 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/28/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes | ||||||
| 09/22/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: PRIMARY CARE | ||||||
| 09/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: DIABETES | ||||||
| 09/19/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Diabetes | ||||||
| 09/13/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/13/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Diabetes Care | ||||||
| 09/12/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Inflammation | ||||||
| 09/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Diabetes | ||||||
| 09/01/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Neuroscience | ||||||
| 08/25/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: PRIMARY CARE | ||||||
| 08/25/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 08/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: DIABETES | ||||||
| 08/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: DIABETES | ||||||
| 08/09/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Inflammation | ||||||
| 08/08/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Diabetes | ||||||
| 08/05/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 08/02/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Urology | ||||||
| 07/28/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $76.95 | General |
| Category: Diabetes | ||||||
| 07/26/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Diabetes | ||||||
| 07/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: PRIMARY CARE | ||||||
| 07/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 18 | 1,357 | 1,806 | $157,259 | $84,973 |
| 2021 | 20 | 1,157 | 1,636 | $135,509 | $77,214 |
| 2020 | 16 | 896 | 1,326 | $95,794 | $48,644 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 359 | $55,645 | $23,769 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 283 | 396 | $41,580 | $21,873 | 52.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 127 | 127 | $19,050 | $16,124 | 84.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 28 | 179 | $13,155 | $7,421 | 56.4% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 37 | 40 | $5,800 | $3,792 | 65.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $3,040 | $2,600 | 85.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 130 | 130 | $3,900 | $2,265 | 58.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 19 | 34 | $3,230 | $1,973 | 61.1% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 174 | 203 | $2,639 | $1,269 | 48.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 35 | 35 | $1,290 | $1,133 | 87.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 13 | 14 | $1,750 | $717.32 | 41.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 25 | 27 | $1,836 | $550.18 | 30.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 103 | 124 | $2,480 | $367.92 | 14.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $472.00 | $338.12 | 71.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $414.00 | $305.04 | 73.7% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2022 | 41 | 55 | $330.00 | $264.05 | 80.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $456.00 | $112.48 | 24.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 30 | 32 | $192.00 | $100.51 | 52.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 188 | 277 | $42,935 | $22,739 | 53.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 234 | 328 | $34,440 | $18,002 | 52.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 97 | 97 | $14,550 | $12,420 | 85.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 41 | 245 | $11,025 | $6,333 | 57.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 46 | 46 | $3,680 | $2,871 | 78.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 46 | 53 | $6,625 | $2,617 | 39.5% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2021 | 27 | 27 | $3,915 | $2,395 | 61.2% |
About Dr. Mark Smith, MD
Dr. Mark Smith, MD is a Family Medicine healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154328433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Smith, MD has received a total of $15,190 in payments from pharmaceutical and medical device companies, with $1,625 received in 2022. These payments were reported across 1,148 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($15,158).
As a Medicare-enrolled provider, Smith has provided services to 3,410 Medicare beneficiaries, totaling 4,768 services with total Medicare billing of $210,830. Data is available for 3 years (2020–2022), covering 54 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location San Antonio, TX
- Active Since 07/01/2005
- Last Updated 11/01/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1154328433
Products in Payments
- FARXIGA (Drug) $1,375
- Ozempic (Drug) $999.64
- XARELTO (Drug) $739.78
- Aimovig (Biological) $723.02
- INVOKANA (Drug) $545.61
- JANUVIA (Drug) $536.80
- JARDIANCE (Drug) $529.30
- AJOVY (Drug) $474.00
- Saxenda (Drug) $466.33
- SYMBICORT (Drug) $448.83
- Victoza (Drug) $368.81
- PROAIR (Drug) $304.47
- Vascepa (Drug) $298.31
- NURTEC ODT (Drug) $280.66
- FASENRA (Biological) $266.00
- MYRBETRIQ (Drug) $261.96
- Tresiba (Drug) $255.85
- Repatha (Biological) $213.12
- LINZESS (Drug) $211.07
- TRULICITY (Drug) $194.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in San Antonio
Dr. Aaron King, M.d, M.D
Family Medicine — Payments: $977,581
George Atiee, M.d, M.D
Family Medicine — Payments: $925,810
Solomon Paley, Md, MD
Family Medicine — Payments: $117,732
Dr. Sarah Samreen, Md, MD
Family Medicine — Payments: $107,899
Dr. Douglas Denham, D.o, D.O
Family Medicine — Payments: $105,590
Melissa Walker, Do, DO
Family Medicine — Payments: $38,955